2012

2016

n

% of sample

mean age (yrs.)

SD

Confidence Intervals

95% confident

n

% of sample

mean age (yrs.)

SD

Confidence Intervals

95% confident

All (A)

533 378

100

46.33

26.42

[46.26;46.40]

All (A)

499 943

100

46.43

26.50

[46.36 ; 46.51]

Female

179 671

33.69

42.11

29.34

[41.97;42.25]

Female

163 908

32.79

41.71

29.28

[41.57 ; 41.85]

Male

353 707

66.31

48.44

24.57

[48.36;48.52]

Male

336 035

67.21

48.74

24.70

[48.66 ; 48.82]

Non diabetic - free chronic disease (ND-FCD)

377 207

70.72^a

39.48

24.38

[39.40;39.56]

Non diabetic - free chronic disease (ND-FCD)

383363

76.69^a

38.9

24.07

[38.83;38.98]

Female

132 997

35.26

35.52

26.63

[35.38;35.66]

Female

132 029

34.44

35.71

26.15

[35.57;35.85]

Male

244 210

64.74

41.63

22.78

[41.54;41.72]

Male

251 334

65.56

41.35

22.9

[41.26;41.44]

Type 2 Diabetic (D)

27 305

5.12^b

71

11.2

[69.87;71.13]

Type 2 Diabetic (closed cohort D)

22 096

4.42^b

72.61

10.75

[72.46 ; 72.75]

Female

 6562

24.03

74

12.2

[73.74;74.34]

Female

 5180

23.44

75.41

12.04

[75.08;75.74]

Male

20743

75.97

70

10.6

[69.87;70.16]

Male

16916

76.56

72.15

10.2

[72.00;72.31]

Type 2 Diabetic mortality rate 2012-2016

5 139

18.82^c

82.08

9.4

[81.83 ; 82.34]

Type 2 Diabetic lost to follow up 2012-2016

70

0.26

Female

1341

26.09

86

8.37

[85.63;86.52]

Female

41

0.62

Male

3798

73.91

 80.7

9.33

[80.38;80.97]

Male

29

0.14